Skip to main content

In animal MS models, a new treatment cleared lesions

By MS Buddy ·

Summarized from Proceedings of the National Academy of Sciences of the United States of America, Nov 2025 · PubMed · DOI. AI-generated summary. Not medical advice.

Animal study · animal models of MS and primates

Research by Senta Kapnick, Christopher Jewell and 20 colleagues at the University of Maryland, College Park in the United States.

Did a treatment placed in lymph nodes clear MS-like nerve damage in animals?

Key Takeaway

In animal models of MS, a treatment placed in immune-system hubs cleared areas of nerve damage without weakening the response to a vaccine challenge.

Stylized nerve fiber with fading dark patches beside a circular immune hub and a small intact shield.
Credibility
Interest
Share:1 min read

What They Found

Researchers placed small, slow-release treatment deposits in immune-system hubs called lymph nodes. In animal models of MS, the treatment helped immune cells stop attacking the nerve covering. Areas of nerve damage disappeared after treatment. One treatment produced lasting improvement in these models. The animals still responded to a vaccine challenge.

Who Should Care and Why

This study used animal models of MS and also tested how well primates tolerated the treatment. The MS findings came from animal models, not people with MS. The treatment was placed in lymph nodes, where immune cells gather. Researchers found that it changed how immune cells responded to the nerve covering. Primates tolerated the treatment well, but the abstract does not describe testing its effects on MS in primates.

Important Considerations

You cannot tell from this study whether the treatment would help people with MS. You also cannot tell whether it would be safe for people. The abstract gives no number of animals studied.

AI-generated summary — for informational purposes only, not medical advice

Read the original abstract

Published in Proceedings of the National Academy of Sciences of the United States of America by et al.. Reproduced from the PubMed record.

Development of tolerogenic, antigen-specific immunotherapies could overcome limitations of existing treatments for inflammatory autoimmune diseases by achieving potent, durable remission without impacting healthy immune surveillance. Here, we deliver diffusion-limited polymer depots to lymph nodes to locally guide T cell fates for the treatment of multiple sclerosis (MS), an autoimmune disease that occurs when the immune system mistakenly attacks myelin. In preclinical MS models, depots loaded with myelin self-antigen and tolerizing cues mediate localized retention of activated CD4 T cells, promote myelin-specific regulatory T cells, and reshape inflammation in the central nervous system (CNS) to eliminate lesions. Selective disease reversal is achieved with a single treatment that induces long-lasting remission without hindering healthy responses to vaccine challenge with foreign antigen. Furthermore, depots offer favorable chemistry and manufacturing control features and are well tolerated in non-human primates. This work supports a clinically feasible concept for inducing safe, effective, antigen-specific tolerance without systemic or repeated dosing.

Categories

Early Research

Explore more research

The app

Check out the MS Buddy app

It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play

Related MS research

Muted blue and clay ribbons curve across an off-white background, wrapped in soft layers of varying thickness.
Planned MS study will test scans to track worsening

11/16/2026

A planned study will use detailed brain scans and blood tests to explore why relapsing-remitting MS

Read More
Two views of spinal cord nerve endings, with fewer chemical particles around the endings on the right.
Lab drug cut chemical release in MS-like mouse tissue

11/15/2026

In tissue from mice with an MS-like disease, a lab drug reduced excess chemical release from nerve e

Read More
A winding path links a DNA strand and a partly broken ring in a simple two-color print.
Review explores how immune genes may shape MS damage

11/13/2026

A review compares MS with harmful drug reactions and proposes ways to test how immune genes, lasting

Read More
Two differently colored molecular shapes near immune cells and a myelinated nerve fiber on a pale background.
Review links vitamin D and vitamin A immune signals to MS

11/13/2026

This review examines how vitamin D and vitamin A signals shape immune activity in MS and other disea

Read More
A folded paper shape beside two winding paths with slightly smoother stretches, in muted colors.
In MS-like mice, treatment helped movement and thinking

11/12/2026

In mice with an MS-like disease, a lab-made protein improved movement and thinking. Researchers also

Read More
A virus-shaped circle and a wrapped nerve fiber sit apart, connected by an incomplete dotted path.
Review proposes how Epstein-Barr virus may drive MS

11/12/2026

A review proposes how the Epstein-Barr virus might contribute to MS. The model brings earlier ideas

Read More

Not all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.